![Mark Siracusa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Mark Siracusa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Nemagen Discoveries, Inc.
![]() Nemagen Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services NemaGen Discoveries, Inc. is a biotech company located in Princeton, NJ. The company focuses on developing therapies for patients with allergic inflammation and mast cell-related diseases. NemaGen's unique approach to drug development involves investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. Recently, NemaGen announced its participation in the NIH I-Corps program to better understand stakeholders' needs and validate the value of its therapies. The company was founded by Mark Siracusa and has been led by CEO Nicholas Shubin since 2022. | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
Präsident | - | - |
Karriereverlauf von Mark Siracusa
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Founder | 1 |
President | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Nemagen Discoveries, Inc.
![]() Nemagen Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services NemaGen Discoveries, Inc. is a biotech company located in Princeton, NJ. The company focuses on developing therapies for patients with allergic inflammation and mast cell-related diseases. NemaGen's unique approach to drug development involves investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. Recently, NemaGen announced its participation in the NIH I-Corps program to better understand stakeholders' needs and validate the value of its therapies. The company was founded by Mark Siracusa and has been led by CEO Nicholas Shubin since 2022. | Commercial Services |
- Börse
- Insiders
- Mark Siracusa
- Erfahrung